In order to evaluate the significance of serum DKK-1 in clinical settings, we analyzed the sensitivities and specificities of serum DKK-1, anti-dsDNA antibodies, and levels of C3 and C4 alone or in a combination for the identification of patients with LN (Table 4). This evidence concerns the gene C3 and lobular neoplasia.